Search This Blog

Wednesday, September 25, 2024

FTC weighs in on reverse-payment generic delay case involving Gilead, Teva

 The FTC has filed an amicus brief in a case involving Gilead and Teva's alleged pay-for-delay scheme to delay generic HIV meds.

https://seekingalpha.com/news/4153357-ftc-weighs-reverse-payment-generic-delay-case-involving-gilead-teva

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.